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TO THE EDITORDiagnostic Accuracy of
Baseline Distal-to-Aortic
Pressure Ratio to Assess
Coronary Stenosis SeverityA Post-Hoc Analysis of the ADVISE II StudyThe demonstration that coronary revascularization on
the basis of functional rather than anatomic stenosis
assessment results in better patient outcomes has
stimulated the interest in fractional ﬂow reserve (FFR)
and other physiological indexes (1). The instanta-
neous wave-free ratio (iFR), introduced in late 2011,
was developed to facilitate the functional assessment
of coronary stenoses by obviating the need for vaso-
dilator drugs (2). The baseline distal coronary pressure
to aortic pressure (Pd/Pa) ratio (calculated as the mean
nonhyperemic transstenotic pressure ratio across
the whole cardiac cycle) has also been proposed as a
simpler index than FFR to estimate stenosis severity,
and a renewed interest in the diagnostic value of
the baseline Pd/Pa ratio has been generated by the
concept of iFR and studies such as RESOLVE (Multi-
center Core Laboratory Comparison of the Instanta-
neous Wave-Free Ratio and Resting Pd/Pa With
Fractional Flow Reserve) (1). The ADVISE II (Adeno-
sine Vasodilator Independent Stenosis Evaluation II)
study was a large, prospective, multicenter, core lab-
oratory–based international study designed to deter-
mine the extent to which iFR accurately reﬂects FFR
(3). Because the RESOLVE study was reported after
the design and approval by ethical review boards of
ADVISE II, Pd/Pa analyses were not included as pre-
speciﬁed endpoints of the study. Despite this, theSEE PAGE 824ADVISE II investigators believe that the meticulously
collected and analyzed data provide an opportunity to
investigate the diagnostic performance of Pd/Pa rela-
tive to FFR. Accordingly, in this post-hoc analysis of
the ADVISE II study, we report the diagnostic accuracy
of Pd/Pa compared with FFR, using the same meth-
odology as for the iFR and FFR comparison.The methodology and results of the ADVISE II
study, as well as the list of participating investigators
and centers, were reported elsewhere (3). Pd/Pa was
calculated as the mean transstenotic pressure ratio
during baseline and was derived from the same car-
diac beats used for iFR computation. Both indexes
were obtained from pressure recordings (a minimum
of 20 s) obtained after crossing the stenosis and
before starting the infusion of adenosine. FFR was
deﬁned as the Pd/Pa ratio during stable hyperemia,
induced by intravenous infusion of adenosine at a
rate of 140/mg/kg/min (3). A total of 919 intermediate
coronary stenoses were investigated during baseline
and hyperemia. From these, 690 pressure recordings
(n ¼ 598) met core laboratory physiology criteria and
were included in this analysis. The median FFR was
0.84 (quartiles 1 and 3: 0.77 and 0.90). The scatterplot
of the baseline Pd/Pa and FFR relationship is shown
in the Figure 1A. Pd/Pa and FFR were strongly corre-
lated (r ¼ 0.84, 95% conﬁdence interval [CI]: 0.82 to
0.86, p < 0.001). Using FFR #0.80 as a cutoff to
deﬁne signiﬁcant stenoses, receiver-operating char-
acteristic (ROC) analysis identiﬁed 0.91 as the optimal
Pd/Pa cutoff, with an area under the ROC curve
(C statistic) of 0.90 (95% CI: 0.88 to 0.93, p < 0.001).
This 0.91 baseline Pd/Pa cutoff classiﬁed correctly
83.2% of total stenoses, with a sensitivity of 66.5%
and speciﬁcity of 92.5%. Figure 1B shows the ROC
curves of iFR and baseline Pd/Pa compared with
FFR #0.80. No signiﬁcant difference between the
areas under the ROC iFR and baseline Pd/Pa curves
was documented (difference in C statistic, 0.00
[95% CI: 0.01 to 0.00], p ¼ 0.350). To achieve 90%
classiﬁcation agreement with FFR, the minimal Pd/Pa
exclusion ranges below and above the optimal 0.91
cutoff were #0.89 (to predict FFR #0.80) and $0.94
(to predict FFR >0.80) and provided a percent
agreement of 90.4%. To achieve 95% classiﬁcation
agreement with FFR, the minimal Pd/Pa exclusion
ranges below and above the same 0.91 cutoff
were #0.88 (to predict FFR #0.80) and $0.97 (to
predict FFR >0.80) and provided a percent agree-
ment of 95.5%. The proportion of patients and ste-
noses free of adenosine by these hybrid Pd/Pa–FFR
strategies amounted to 75.6% (95% CI: 71.9% to
79.0%) and 78.4% (95% CI: 75.1% to 81.4%), respec-
tively, for a 90% classiﬁcation agreement and to
47.0% (95% CI: 42.9% to 51.1%) and 51.4% (95% CI:
47.6% to 55.2%), respectively, for a 95% classiﬁcation
FIGURE 1 Pd/Pa and FFR Relationship
(A) Scatterplot of the Pd/Pa and FFR relationship. (B) Receiver-operating characteristic curves of iFR and Pd/Pa compared with FFR #0.80.
CI ¼ conﬁdence interval; FFR ¼ fractional ﬂow reserve; IFR ¼ instantaneous wave-free ratio; Pd/Pa ¼ baseline distal coronary pressure to aortic
pressure.
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835agreement. Finally, even in the most conservative
scenario (100% agreement), 14% of stenosis with a
baseline Pd/Pa <0.81 would not require hyperemic
stress for correct classiﬁcation.
The design of the ADVISE II study offers several
methodological advantages over previous iFR versus
FFR comparisons that reduces the potential for bias
and threats to statistical validity. These include the
following: 1) dedicated and prospectively deﬁned
data collection; 2) better data control; 3) additional
checks for data integrity and consistency; and
4) a level of clinical detail appropriate to address the
research question. Therefore, the ADVISE II study
allows several strong conclusions to be drawn. First,
both baseline Pd/Pa and iFR are strongly correlated
with FFR. Second, at the extremes of the distribution
of values of both of these indexes, the probability of
signiﬁcant stenosis (FFR #0.80 at the low end) and
nonsigniﬁcant stenosis (FFR >0.80, at the high end)
is very high. Indeed, both indexes could reach a
100% classiﬁcation agreement at the low end
(iFR <0.73, Pd/Pa <0.81), whereas only iFR reached a
100% classiﬁcation match at the high end (value of
1.0). These ﬁndings conﬁrm that when FFR is used as
a reference, a proportion of stenoses can be classiﬁed
correctly without hyperemic stress, and that an in-
verse relationship between diagnostic accuracy and
reduction in adenosine use exists. In this interpre-
tation, however, the following has to be kept in
mind: 1) iFR, Pd/Pa, and FFR are intrinsically corre-
lated because they all rely on pressure as a surrogateof myocardial ﬂow impairment; 2) Pd/Pa and FFR
have a greater inherent association because they
both assess pressure throughout the cardiac cycle
and not over a ﬁnite period of time in diastole; and
3) FFR is used as the standard of reference. In this
regard, 2 recent head-to-head comparisons of the
diagnostic accuracy of iFR, Pd/Pa, and FFR that used
as a reference standard nonpressure-derived tests of
myocardial ﬂow impairment (coronary ﬂow reserve
and single-photon emission computed tomography,
both with a wealth of supportive outcome data [4,5])
found a similar discrimination power for both resting
(Pd/Pa, iFR) and hyperemic (FFR) indexes. Further
studies should address whether differences between
resting and hyperemic indexes in terms of the iden-
tiﬁcation of revascularization targets are clinically
relevant. Finally, the calculation of Pd/Pa in the
ADVISE II study slightly differs from that used in
clinical practice because Pd/Pa was derived from
optimal beats selected by the iFR calculation algo-
rithm. These, in addition to the demanding meth-
odology in the catheterization laboratory and
analyses mandated in the ADVISE II study, might
help explain why, in contrast, the RESOLVE study
could not ﬁnd an upper boundary of baseline Pd/Pa
that predicted with $90% accuracy a negative FFR
value. Further clinical studies should address
whether the larger spread of possible iFR values and
its more balanced sensitivity and speciﬁcity (3)
confers on this index a pragmatic value above the
Pd/Pa.
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